Cite
Adoptive immunotherapy for superficial bladder cancer with autologous macrophage activated killer cells.
MLA
Thiounn, Nicolas, et al. “Adoptive Immunotherapy for Superficial Bladder Cancer with Autologous Macrophage Activated Killer Cells.” The Journal of Urology, vol. 168, no. 6, Dec. 2002, pp. 2373–76. EBSCOhost, https://doi.org/10.1016/S0022-5347(05)64148-1.
APA
Thiounn, N., Pages, F., Mejean, A., Descotes, J.-L., Fridman, W.-H., & Romet-Lemonne, J.-L. (2002). Adoptive immunotherapy for superficial bladder cancer with autologous macrophage activated killer cells. The Journal of Urology, 168(6), 2373–2376. https://doi.org/10.1016/S0022-5347(05)64148-1
Chicago
Thiounn, Nicolas, Franck Pages, Arnaud Mejean, Jean-Luc Descotes, Wolf-H Fridman, and Jean-Loup Romet-Lemonne. 2002. “Adoptive Immunotherapy for Superficial Bladder Cancer with Autologous Macrophage Activated Killer Cells.” The Journal of Urology 168 (6): 2373–76. doi:10.1016/S0022-5347(05)64148-1.